SIGHT SCIENCES INC(NASDAQ:SGHT) stock News

SGHT Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Sight Sciences, Inc.

Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO

2 days ago - By: Zacks Investment Research - Mentions: JNJ ALC GKOS

Glaukos Builds Dual Growth Engines Amid Market Headwinds

9 days ago - By: Sight Sciences, Inc.

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

14 days ago - By: Benzinga

What 4 Analyst Ratings Have To Say About Sight Sciences

a month ago - By: Zacks Investment Research

Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics

a month ago - By: Zacks Investment Research - Mentions: DRIO

Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates

a month ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

a month ago - By: Zacks Investment Research - Mentions: VCYT

Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates

a month ago - By: Sight Sciences, Inc.

Sight Sciences Announces the Results of a Cost-Utility Analysis Demonstrating Cost Savings and Greater Health Utility with the TearCare® System Compared to Cyclosporine 0.05% for Treating Meibomian Gland Disease-Associated Dry Eye Disease

a month ago - By: Sight Sciences, Inc.

Sight Sciences Announces the Publication of the 24-Month Results of the SAHARA RCT Demonstrating the Durability of the TearCare® Procedure for the Treatment of Dry Eye Disease

a month ago - By: Sight Sciences, Inc.

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025

4 months ago - By: Zacks Investment Research

Sight Sciences (SGHT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

4 months ago - By: Zacks Investment Research - Mentions: CLPT

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

4 months ago - By: Sight Sciences, Inc.

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

4 months ago - By: Sight Sciences, Inc.

Sight Sciences Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 Revenue Guidance

4 months ago - By: Zacks Investment Research - Mentions: AORT

Artivion (AORT) Lags Q1 Earnings Estimates

4 months ago - By: Sight Sciences, Inc.

Sight Sciences to Report First Quarter 2025 Financial Results on May 8, 2025

4 months ago - By: Sight Sciences, Inc.

Sight Sciences Appoints Gary Burbach to its Board of Directors

5 months ago - By: Sight Sciences, Inc.

Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio

5 months ago - By: Sight Sciences, Inc.

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

6 months ago - By: Sight Sciences, Inc.

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

6 months ago - By: Sight Sciences, Inc.

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

7 months ago - By: Sight Sciences, Inc.

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day

9 months ago - By: Sight Sciences, Inc.

Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options

10 months ago - By: Sight Sciences, Inc.

Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference

a year ago - By: Sight Sciences, Inc.

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

a year ago - By: Sight Sciences, Inc.

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

SIGHT SCIENCES INC (SGHT) Stock News

SGHT Latest News, Press Relases and Analysis